The R&D World Index (RDWI) for the week ending June 17, 2022, closed at 4,413.63 for the 25 companies in the RDWI. The Index was down -.3.44% (or -157.22 basis points) from the week ending June 10, 2022. Two of the 25 RDWI members gained value from 0.86% (Oracle) to 6.67% (Cisco). Twenty-three of the…
BD debuts compact flow cytometry cell analyzer
Flow cytometry is a powerful technology given its ability to analyze the physical and chemical properties of cells and particles. But many laboratories struggle to find space for advanced flow cytometry cell analyzers. BD (NYSE:BDX) has responded to that challenge with its benchtop FACSymphony A1 cell analyzer. BD designed the fluorescence-activated cell analyzer to support…
How to build a foundation for the next phase of Alzheimer’s disease research
Alzheimer’s disease has one of the highest financial burdens. The Alzheimer’s Association estimates that the cost of the disease in the U.S. will hit $355 billion in 2021. “Not only is Alzheimer’s one of the most expensive, it’s probably one of the most devastating diseases of humans,” said Dr. Allan Levey, professor and chairman of…
Abbott researchers help discover a clue to an HIV cure
Abbott announced today that a team including its scientists has uncovered a rare group of Democratic Republic of Congo residents who are HIV positive but have almost nonexistent viral loads without using antiretroviral treatments. This group of “HIV elite controllers” opens up a new area for researchers to discover biological trends that could inform the…
Thermo Fisher Scientific acquires Propel Labs and its cell sorting tech
Thermo Fisher Scientific (NYSE:TMO) announced today that it acquired cell sorting technology assets from SIDIS Corp. subsidiary Propel Labs. Waltham, Mass.-based Thermo Fisher’s agreement with Propel Labs stipulates that the recently introduced Bigfoot spectral cell sorter and approximately 40 employees will become part of Thermo Fisher’s biosciences business unit, while Propel Labs will continue to operate…